Retatrutide: Availability Timeline for New Weight-Loss Drug Explored | Retatrutide News

Retatrutide is a weight-loss drug being developed by Eli Lilly, part of the GLP-1 agonist class. Its public availability timeline is still unclear, pend...
Weight Loss · October 16, 2026